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Abstract
Objectives: To adequately monitor the course of cognitive functioning in persons with moderate to severe dementia,
relevant cognitive tests for the advanced dementia stages are needed. We examined the ability of a test developed for the
advanced dementia stages, the Severe Impairment Battery Short version (SIB-S), to measure cognitive change over time.
Second, we examined type of memory impairment measured with the SIB-S in different dementia stages. Methods: Parti-
cipants were institutionalized persons with moderate to severe dementia (N= 217). The SIB-S was administered at
6-month intervals during a 2-year period. Dementia severity at baseline was classified according to Global Deterioration
Scale criteria. We used mixed models to evaluate the course of SIB-S total and domain scores, and whether dementia
stage at baseline affected these courses. Results: SIB-S total scores declined significantly over time, and the course of
decline differed significantly between dementia stages at baseline. Persons with moderately severe dementia declined
faster in mean SIB-S total scores than persons with moderate or severe dementia. Between persons with moderate and
moderately severe dementia, there was only a difference in the rate of decline of semantic items, but not episodic and
non-semantic items. Conclusions: Although modest floor and slight ceiling effects were noted in severe and milder cases,
respectively, the SIB-S proved to be one of few available adequate measures of cognitive change in institutionalized per-
sons with moderate to severe dementia. (JINS, 2019, 25, 204–214)
Keywords: Cognition, Cognitive decline, Dementia, Dementia stages, Institutionalization, Longitudinal studies,
Neuropsychological tests
INTRODUCTION
Dementia due to neurodegenerative disease is primarily
characterized by a progressive deterioration of cognitive
functioning (Grand, Caspar, & Macdonald, 2011). This
deterioration eventually leads to increased dependency on
others, and it is a strong indicator of institutionalization
(Gaugler, Yu, Krichbaum, & Wyman, 2009). Consequently,
the vast majority of persons with dementia reside in institu-
tions 8 years after the initial dementia diagnosis (Luppa,
Luck, Brähler, König, & Riedel-Heller, 2008). Institutiona-
lized persons with dementia have on average more severe
dementia than community dwelling persons with dementia
(Boersma, Eefsting, Van Den Brink, & Van Tilburg, 1997),
and relevant cognitive tests may be needed to monitor the
course of cognitive functioning in more advanced dementia
stages. In this way, pharmacological and non-
pharmacological interventions targeting cognition, which
are increasingly implemented in institutionalized persons
with dementia, can be adequately evaluated.
Correspondence and reprint requests to: Evelien Wolf, Section Clinical
Neuropsychology, Vrije Universiteit Amsterdam, Van der Boechorststraat 7,
1081 BT Amsterdam, The Netherlands. E-mail address: e.t.wolf@vu.nl
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One of the major problems with measuring the course of
cognitive functioning in persons with dementia is floor
and ceiling effects of cognitive tests. Although the
Mini-Mental State Examination (MMSE; Folstein, Fol-
stein, & McHugh, 1975) has often been used to monitor the
course of cognitive functioning in persons with mild to
moderate dementia (Galasko, Gould, Abramson, & Sal-
mon, 2000; Thomas, Albert, Petersen, & Aisen, 2016), it
shows a floor effect in more advanced dementia (Galasko
et al., 2000). Several tests for advanced dementia have
been developed. Examples of commonly used tests are the
Severe Cognitive Impairment Profile (SCIP; Peavy et al.,
1996), Severe Mini-Mental State Examination (SMMSE;
Harrell, Marson, Chatterjee, & Parrish, 2000), and Severe
Impairment Battery (SIB; Saxton, McGonigle-Gibson,
Swihart, Miller, & Boller, 1990; Panisset, Roudier, Saxton,
& Boiler, 1994).
Compared to the MMSE, these three tests have shown
reduced floor effects in advanced dementia. Although an
ability to detect cognitive change over time was established
for both the SCIP (Peavy et al., 1996) and the SIB (Black
et al., 2007; Feldman et al., 2005; Schmitt et al., 1997; Wild
& Kaye, 1998), these tests take 30 minutes or more to
administer, and this may be too long for persons with an
MMSE-score of 5 or below or for those who are very agitated
(Saxton et al., 2005). The SMMSE can be administered in
5minutes, but has some problems with measuring cognitive
change over time (Harrell et al., 2000). It is important that a
test for advanced dementia has a short administration time
and is able to detect cognitive change over time.
A short version of the SIB (SIB-S) was developed to make
the SIB more suitable for persons with a short attention span
and thus to minimize floor effects (Saxton et al., 2005). The
SIB-S takes approximately 10–15min to administer, and was
validated in several studies (Ahn, Kim, Saxton & Kim, 2007;
de Jonghe, Wetzels, Mulders, Zuidema, & Koopmans, 2009;
Saxton et al., 2005). Low SIB-S scores were associated with
cognitive impairment as measured with the MMSE, dementia
severity, and functional dependency in activities of daily
living. In addition, very minimal floor effects were evidenced
(Ahn et al., 2007; de Jonghe et al., 2009; Saxton et al., 2005).
The ability of the SIB-S to measure cognitive change in
persons with moderate to severe dementia, however, has not
yet been studied.
Our main objective was to examine the ability of the SIB-S
to measure cognitive change in institutionalized persons with
moderate to severe dementia. To examine to what extent the
SIB-S is susceptible to floor and ceiling effects in the long-
term, we also took into account the different dementia stages.
In addition, as during the early phases of Alzheimer’s disease
(AD) the decline of semantic memory is often less pro-
nounced and less consistent compared to episodic memory
(Hodges & Patterson, 1995; Perry, Watson, & Hodges,
2000), it is possible that aspects of semantic memory are
better preserved in the advanced stages of dementia. There-
fore, we explored if the ability of participants to complete
semantic, non-semantic, and episodic memory items of the
SIB-S was related to their diagnosed dementia stage and to
their overall cognitive functioning.
METHODS
Subjects
This cohort study was part of a larger prospective cohort
study in which participants were enrolled from 14 dementia
special care units from 9 nursing homes in the Netherlands
(Wetzels, Zuidema, de Jonghe, Verhey, & Koopmans, 2010).
This same sample has been used to validate the SIB-S in the
Netherlands (de Jonghe et al., 2009). Participants’ elderly
care physicians (Koopmans, Pellegrom, & van der Geer,
2017) systematically screened all participants for inclusion.
Participants were considered for inclusion provided they: (1)
met the Diagnostic and Statistical Manual of Mental Dis-
orders fourth edition criteria for dementia (American Psy-
chiatric Association, 2000); (2) had no life-threatening
disease at the time of inclusion; (3) had to reside in a nursing
home for at least 4 weeks. Participants were followed for 2
years and all assessments were administered at baseline and
subsequently during 4 biannual follow up visits.
Measures
The course of cognitive functioning was assessed with the
Severe Impairment Battery Short version (SIB-S; Saxton
et al., 2005). This test, which was developed for the more
advanced dementia stages, has a total score ranging from 0
to 50. See Table 1 for a representation of the individual
items of the SIB-S per subscale. The SIB-S has been trans-
lated into Dutch and has been validated (de Jonghe et al.,
2009). Furthermore, the SIB-S has a high reliability and a
high concurrent validity with the MMSE (de Jonghe et al.,
2009).
To create a domain of items that relied mostly on Semantic
memory, we added the Language, Praxis, Visuospatial abil-
ity, and Construction subscales, creating a score ranging from
0 to 31. For the Episodic memory domain, we used the
Memory subscale minus item 3 (immediate recall of the
examiner’s name) with a score ranging from 0 to 5. To create
a domain of items that relied least on semantic memory
(Memory-Orientation-Attention), we added the Memory,
Orientation, and Attention subscales with a score ranging
from 0 to 13. In case a participant could not communicate due
to severe dementia a total score of 0 was given. If a partici-
pant did not cooperate at a particular assessment, this
assessment was registered as missing.
Type of dementia diagnosis was established by the elderly
care physicians using international consensus criteria
(McKhann et al., 1984; Roman et al., 1993) and the Dutch
consensus guidelines for AD, vascular dementia (VaD),
mixed AD/VaD, and other diagnosis. Independently of the
elderly care physicians, one of the authors (R.B.W.) checked
eligibility and diagnosis of all participants against their
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clinical notes. In cases of doubt, consensus meetings were
organized to ensure inclusion of participants who met the
inclusion criteria. See Table 2 for a representation of
dementia subtypes diagnosed in the sample.
The Global Deterioration Scale (GDS) for Primary
Degenerative Dementia (Reisberg, Ferris, de Leon, & Crook,
1982) was used to determine the severity/stage of dementia at
baseline. This assessment scale consists of a seven-point
scale: (1) no cognitive decline; (2) mild memory loss reported
by the participant, but the tests show no loss of function; (3)
mild cognitive impairment (MCI); (4) early dementia;
(5) moderate dementia; (6) moderately severe dementia; and
(7) severe cognitive decline/late dementia. In this particular
cohort study, only participants with a GDS-score of 5, 6, or 7
were included.
The Mini-Mental State Examination (MMSE; Folstein
et al., 1975) was administered for baseline characteristics.
Activities of daily living (ADL) dependency was measured
with section G of the Interrai Long-Term Care Facility scale
(2005, version 07). For this study, the hierarchical ADL scale
was used, which consists of 4 of the ADL items of the Interrai
(Morris, Fries, & Morris, 1999). A hierarchical decision tree
was used to obtain ADL dependency scores: (0) independent
(in all 4 ADL items), (1) supervision, (2) limited, (3) exten-
sive 1, (4) extensive 2, (5) dependent, and (6) total depen-
dence. The hierarchical ADL scale has good to excellent
interrater reliability and a Cronbach’s alpha of .90 (Morris
et al., 1999).
Ethical Considerations
This study was approved by the regional research ethics
committee and completed in accordance with the Helsinki
Declaration. The participants and/or their relatives and legal
guardians were informed about the study and gave their
written consent.
Statistical Analysis
The analyses were conducted with Statistical Package for
Social Sciences (SPSS) version 23 and R version 3.4.2 (R
Core Team, 2017). To compare the baseline characteristics
between the different dementia stages (GDS-score), Pearson
χ2-tests for gender, education, medication use, and ADL
dependency were conducted. The data for age, years in nur-
sing home, years in nursing home unit, MMSE-score, and
SIB-S score were not normally distributed in all separate
GDS-groups. Therefore, non-parametric Independent Sam-
ples Kruskal-Wallis Tests were conducted to compare those
variables between GDS-groups.
To examine concurrent validity, Kendall’s tau correla-
tions between total SIB-S score and ADL dependency were
calculated for all five assessments. To get an indication of
how much measured SIB-S scores were spread around a
“true” score, we calculated standard error of measurement
Table 1. SIB-S items per subscale
Item number Score
Social Interaction
1. Shake hands 0, 1, 2
2. Follow directions 0, 1, 2
Memory
3. Immediate recall of examiner’s name 0, 1, 2
12. Delayed recall of examiner’s name 0, 1, 2
21. Recall of coloured block 0, 1, 2
25. Delayed recall of cup 0, 1
Orientation
4. Subject’s name 0, 1, 2
7. City name 0, 1, 2
Language
5. Write name 0, 1, 2
6. Copy name 0, 1, 2
8. Responsive naming – cup 0, 1, 2
9. Reading comprehension 0, 1, 2
10. Verbal comprehension 0, 1, 2
13. Confrontational naming – cup 0, 1, 2
15. Object naming – cup 0, 1, 2
17. Forced choice naming – cup 0, 1
18. Confrontational naming – spoon 0, 1, 2
19. Color naming – blue 0, 1, 2
23. Color naming – red 0, 1, 2
Attention
11. Digit span 0, 1, 2
Praxis
14. Using cup – photograph 0, 1, 2
16. Using cup – cup 0, 1, 2
Visuospatial ability
20. Color matching 0, 1, 2
22. Color discrimination 0, 1, 2
Construction
24. Drawing – square 0, 1, 2
Orienting to name
26. Orienting to name 0, 1, 2
Table 2. Subtypes of dementia for the whole sample
Subtype n
Possible/probable AD 82
Possible/probable VaD 24
Mixed AD/VaD 11
Mixed AD/not otherwise specified 8
Mixed VaD/not otherwise specified 2
Mixed VaD/Dementia with Lewy Bodies 2
Mixed VaD/Parkinson’s Dementia/not otherwise specified 1
Mixed Dementia with Lewy Bodies/not otherwise specified 1
Mixed Frontotemporal Dementia/not otherwise specified 1
Mixed Parkinson’s Dementia/not otherwise specified 1
Dementia with Lewy Bodies 4
Frontotemporal Dementia 4
Parkinson’s Dementia 1
Not otherwise specified 75
AD, Alzheimer’s disease; VaD, vascular dementia.
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(SEM) for all five assessments with the following formula:
SEM= S * √(1–rkk).
Growth curve models were used to measure the course of
SIB-S scores over time. These models can handle missing
data and take into account multiple assessments within one
subject. The standard model consisted of two levels: SIB-S
scores at level 1, nested within subjects (level 2). Time
(measured in days between T0 (representing 0 days) and T1,
T0 and T2, T0 and T3, and T0 and T4) was the continuous
independent variable and age at baseline (centered) was
added as additional covariate.
To assess whether the course of SIB-S scores over time
showed non-linearity, an additional quadratic Time regressor
was added to the standard model. To analyze the difference in
the course of SIB-S scores over time between dementia
stages, GDS-score (3 categories) and a GDS-score by Time
interaction were added as independent variables to the stan-
dard model. In case of a significant GDS-score by Time
interaction, separate models for GDS-score were run to ana-
lyze the effect of Time on SIB-S scores.
To analyze if there were different effects for SIB-S
domains, above mentioned growth curve models were also
run for the domains Semantic memory, Episodic memory,
and Memory-Orientation-Attention.
All models included a random intercept across partici-
pants. Random slopes for Time (heterogeneous first-order
autoregressive structure) were added if the Likelihood Ratio
Test between the random intercept model and the model with
additional random slopes was significant (p< .05).
A Pearson χ2-test was conducted to examine if the number
of dropouts at the fifth assessment differed between GDS-
groups. In addition, a one-way analysis of variance
(ANOVA) was conducted to assess for significant differences
in the percentage of total missing assessments between dif-
ferent GDS-groups. Furthermore, a one-way ANOVA,
Pearson χ2-test or Mann-Whitney U (dependent on the out-
come variable) was conducted to check whether there were
differences in baseline characteristics between participants
that completed and participants that did not complete the fifth
assessment.
To check if GDS-score at baseline could predict the
amount of individual variability in SIB-S scores over time,
we conducted a non-parametric Independent Samples
Kruskal-Wallis Test. To characterize individual progression
characteristics of SIB-S scores over time, we performed a
linear regression analysis [with SIB-S as dependent and Time
(in days) as predictor] for each separate participant with at
least three SIB-S assessments. The residual sums-of-squares
(rss) was taken as the variability of the decline. To correct for
missing assessments, we divided the rss by the number of
assessments. In case of a significant effect of GDS-score on
the variability of decline, Independent Samples Mann-
Whitney U Tests were conducted to check which GDS-
groups differed in the variability of decline.
To gain insight about the relationship between individual
items of the SIB-S and overall cognitive functioning mea-
sured with the SIB-S, items were first ranked by how many
participants could still successfully complete the item. As a
measure for the items’ completion rate, per item the mean
normalized SIB-S score was calculated, where the average
and associated standard deviation were taken over all parti-
cipants and all tests. Normalization was necessary before
ranking, because item 17 and 25 are on a 0–1 scale, whereas
the rest of the items are on a 0–1–2 scale. After ranking the
items, test subjects were separated into 6 groups by their total
SIB-S score. The scores 0 and 50 were each taken as a
separate group, because these scores would show no varia-
tion in individual item scores. The rest of the population was
separated in 4 equally sized groups. Then we plotted per item
the completion rate by different stages of overall cognitive
functioning. The plots show the items ranked based on the
whole population, but with the mean normalized SIB-S score
per item per group.
Alpha-level was set at .05. For post hoc analyses, Bon-
ferroni correction was applied (α= .017).
RESULTS
Sample Characteristics
A total of 290 participants were eligible for inclusion. For 15
participants, no SIB-S data were available, and 29 partici-
pants did not meet inclusion criteria for this particular cohort.
Twenty-nine participants scored zero on all SIB-S assess-
ments. These participants probably did not understand test
instructions at any assessment, and were excluded from fur-
ther analyses. In the 217 remaining participants, no sig-
nificant gender, age, education, or medication use differences
were found between GDS-groups at baseline. As expected,
MMSE-scores and SIB-S scores differed between GDS-
groups, where persons with severe dementia had the lowest
mean scores on the MMSE and SIB-S. Furthermore, persons
with more severe dementia were on average most ADL
dependent and were institutionalized the longest. See Table 3
for baseline characteristics and comparison between GDS-
groups.
A minimum of 1 SIB-S assessment (n= 217) and a
maximum of 5 SIB-S assessments (n= 55) were available
for each participant. Twenty participants had missing data at
an assessment before their last assessment; thus, the number
of participants at T4 (n= 70) was different from the number
of participants that completed all 5 SIB-S assessments.
Participants missed an average of two of five assessments.
Reasons for dropping out were the move to another insti-
tution, death, too ill to be tested, or refusal of the participant
to further cooperate. Participants who dropped out were
older (on average 2.73 years; F(1,216)= 7.834; p= .006;
η2= .035) and were more likely to use hypnotics
(χ2(1)= 11.889; p= .020; η2= .026) than participants who
completed the fifth assessment. There were no other sig-
nificant differences in baseline characteristics between par-
ticipants who completed and participants who dropped out
at the fifth assessment.
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Concurrent Validity
Low scores on SIB-S were associated with high ADL
dependency scores on all five assessments, (T0: Kendall’s
tau= -.363, p< .001; T1: Kendall’s tau= -.452, p< .001; T2:
Kendall’s tau= -.478, p< .001; T3: Kendall’s tau= -.558,
p< .001; T4: Kendall’s tau= -.665, p< .001).
Table 3. Baseline characteristics of the sample
Baseline characteristics
Total sample
(N= 217)
GDS-score 5
(n= 59)
GDS-score 6
(n= 108)
GDS-score 7
(n= 50) p-value η2/V
Age in years
Mean (SD) 83.91 (6.82) 83.89 (6.44) 83.35 (6.43) 85.13 (7.97) .274 η2= .003
Median 84.47 84.76 83.78 85.82
Range 59.30–102.20 59.30–97.62 60.51–96.58 65.51–102.20
Gender, men (%) 23.5 30.5 23.1 16 .216 V= .121
Education (%) .284 V= .200
Primary 26.3 20.3 24.1 38
Low vocational
secondary
19.4 20.3 21.3 14
Mid vocational
secondary
6.9 6.8 8.3 4
High vocational
secondary
2.3 5.1 1.9 0
University .9 0 .9 2
Missing values 44.2 47.5 43.5 42
Years in nursing home n= 213 n= 57 n= 106 n= 50 < .001 η2= .072
Mean (SD) 2.69 (2.01) 2.15 (2.00) 2.57 (1.96) 3.55 (2.05)
Median 2.06 1.59 1.96 3.61
Range .10–10.28 .12–10.28 .18–9.08 .10–8.27
Years in nursing home unit n= 213 n= 57 n= 106 n= 50 < .001 η2= .095
Mean (SD) 2.36 (1.94) 1.80 (1.84) 2.22 (1.84) 3.32 (1.95)
Median 1.81 1.16 1.71 2.78
Range .05–10.28 .05–10.28 .17–9.08 .10–7.57
Medication use (%)
Antipsychotic 35.0 32.2 32.4 44.0 .332 V= .103
Antidepressant 27.6 22 31.5 26.0 .412 V= .091
Hypnotic 13.8 13.6 14.8 12.0 .935 V= .033
Anxiolytic 18.4 15.3 17.6 24.0 .492 V= .083
NMDA inhibitor 5.5 8.5 4.6 4.0 .586 V= .079
ADL dependency
Independent 2.3 5.1 1.9 0 < .001 V= .390
Supervision 12 28.8 8.3 0
Limited 6.9 8.5 9.3 0
Extensive 1 33.6 35.6 38.9 20.0
Extensive 2 6.0 5.1 5.6 8.0
Dependent 27.2 16.9 27.8 38.0
Total dependence 12.0 0 8.3 34.0
MMSE n= 213 n= 59 n= 105 n= 49 < .001 η2= .528
Mean (SD) 7.19 (6.06) 13.08 (4.79) 6.75 (4.74) 1.02 (1.93)
Median 7 13 7 0
Range 0-24 1-24 0–17 0–7
SIB-S
Mean (SD) 27.50 (15.48) 40.44 (7.04) 29.49 (12.12) 7.94 (8.74) < .001 η2= .528
median 31 42 32 4.5
range 0–50 16–50 0–48 0–32
Note. GDS-score 5, moderate dementia; GDS-score 6, moderately severe dementia; GDS-score 7, severe cognitive decline/late dementia; p-value, results of the
Pearson χ²-test for gender, education, medication use, ADL dependency, and Independent Samples Kruskal-Wallis Test for age, years in nursing home (unit),
MMSE-score, and SIB-S score to compare between GDS-scores; η2, eta squared, effect size for Independent Samples Kruskal-Wallis Test; V, Cramer’s V, effect
size for Pearson ‘s χ²-test.
N/n, number of participants; SD, standard deviation; MMSE, Mini-Mental State Examination; SIB-S, Severe Impairment Battery Short version.
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SEM
For the SIB-S, the SEM was 3.21 points for T0, 2.89 points for
T1, 2.91 points for T2, 2.96 points for T3, and 2.62 points for T4.
Growth Curve Models
For coefficients and standard deviations for all growth curve
models, see Table 4.
Course of total SIB-S scores over time
Average total SIB-S scores declined significantly over time,
F(1,114.058)= 65.240, p< .001. The addition of a quadratic
time variable (Time²) to this model was not significant,
χ2(1)= 1.245, p> .05. See Table 5 for number of participants
and mean SIB-S scores per assessment. Not every participant
declined in SIB-S scores between two assessments. Of the
217 participants, 152 had more than one assessment; whereas
67.1% of the participants scored lower, 9.2% were equiva-
lent, and 23.7% scored higher at their last assessment in
comparison to their first assessment.
Effect of baseline dementia stage (GDS-score) on the
course of SIB-S total scores over time
Baseline GDS-score had an effect on the rate of decline in
SIB-S scores over time, F(2,104.960)= 8.517, p< .001.
Table 4. Growth curve models for SIB-S total and domain scores
Total SIB-S Semantic memory Episodic memory M-O-ATT
Effect of Time for the whole sample
Fixed effects (coefficients and SE)
Constant 27.902(1.073) 17.122(.734) 1.555(.096) 6.199(.264)
Age (centered) .041 (.155) .030(.105) − .018(.013) .008(.038)
Time (days from T0) − .012(.001)*** − .008(.001)*** − .0008(.0002)*** − .002(.0003)***
Effect of Time² for the whole sample
Fixed effects (coefficients and SE)
Constant 27.748(1.082) 17.060(.740) 1.499(.099) 6.157(.268)
Age (centered) .042(.155) .030(.105) − .018(.013) .008(.038)
Time (days from T0) − .009(.003)** − .006(.002)** .0002(.0005) − .002(.001)
Time² < − .0001(< .0001) < .0001(< .0001) < .0001(< .0001)* < .0001(< .0001)
Effect of GDS x Time
Fixed effects (coefficients and SE)
Constanta 29.896(.999) 18.369(.713) 1.558(.110) 6.523(.257)
Age (centered) .171(.102) .113(.072) − .010(.010) .042(.026)
Time (days from T0)a − .018(.002)*** − .012(.001)*** − .001(.0002)*** − .004(.0006)***
GDS (6 compared to 5) 11.434(1.673)*** 7.705(1.194)*** 1.126(.184)*** 3.062(.431)***
GDS (6 compared to 7) −21.970(1.774)*** − 14.380(1.267)*** − 1.334(.196)*** − 4.903(.457)***
GDS (7 compared to 5) 33.404(1.984)*** 22.086(1.417)*** 2.460(.218)*** 7.966(.512)***
GDS (6 compared to 5) × Time .009(.003)** .006(.002)** .0002(.0004) .001(.0009)
GDS (6 compared to 7) × Time .013(.003)*** .009(.002)*** .0009(.0004)* .003(.0009)**
GDS (7 compared to 5) × Time − .004(.004) − .003(.003) − .0007(.0004) − .002(.001)
Effect of Time for GDS-score 5
Fixed effects (coefficients and SE)
Constant 41.330(.910) 26.033(.693) 2.682(.152) 9.591(.259)
Age (centered) − .127(.134) − .079(.097) − .048(.021)* − .042(.038)
Time (days from T0) − .008(.003)** − .004(.002) − .0008(.0003)** − .002(.0007)**
Effect of Time for GDS-score 6
Fixed effects (coefficients and SE)
Constant 30.046(1.177) 18.472(.848) 1.570(.127) 6.560(.297)
Age (centered) .421(.181)* .293(.130)* .011(.018) .103(.045)*
Time (days from T0) − .018(.002)*** − .012(.002)*** − .001(.0003)*** − .004(.0007)***
Effect of Time for GDS-score 7
Fixed effects (coefficients and SE)
Constant 8.045(1.271) 4.071(.789) .210(.066) 1.643(.324)
Age (centered) .031(.154) .011(.095) − .008(.007) .012(.039)
Time (days from T0) − .004(.001)** − .002(.001)* − .0002(.0002) − .0007(.0005)
Note. GDS-score 5, moderate dementia; GDS-score 6, moderately severe dementia; GDS-score 7, severe cognitive decline/late dementia.
a Group with GDS-score 6 was used as reference group.
*p< .05.
** p< . 01.
*** p< .001.
SIB-S, Severe Impairment Battery Short version; M-O-ATT, Memory-Orientation-Attention domain.
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Mean SIB-S scores of persons with GDS-score 6 declined
significantly faster than persons with GDS-score 5
(t(110.993)= 2.700; p= .008) or GDS-score 7
(t(103.490)= 3.912; p< .001). By contrast, there was no
significant difference in the course of SIB-S scores over time
between persons with GDS-score 5 and persons with GDS-
score 7 (t(99.799)= 1.083; p= .282). The average decline on
the SIB-S per half year (182.5 days) was 1.41 points for
persons with GDS-score 5 (F(1,37.789)= 8.597; p= .006),
3.26 points for persons with GDS-score 6
(F(1,49.912)= 51.533; p< .001), and .82 points for persons
with GDS-score 7 (F(1,119.121)= 9.559; p= .002). See
Figure 1 for a visual representation of the progression of SIB-
S scores over time for each dementia stage. As can be seen in
Figure 1, there is considerable variability between individual
participants with the same GDS-score in their course of SIB-
S scores over time.
In addition, an Independent Samples Kruskal-Wallis Test
showed a significant difference between GDS-groups in
individual variability in SIB-S scores over time, H= 20.332,
p< .001, η2= .150. Persons with GDS-score 7 had less
individual variability than persons with GDS-score 5
(U= 313.000; p= .004; η2= .035) or GDS-score 6
(U= 427.000; p< .001; η2= .208).
The number of dropouts at the fifth assessment was sig-
nificantly different between persons with GDS-score 5
(64.4%), GDS-score 6 (75%), and GDS-score 7 (56%),
Pearson χ2(2)= 5.520, p= .049, V= 0.159. However, there
was no significant difference in the percentage of total miss-
ing assessments between persons with GDS-score 5 (39.3%),
GDS-score 6 (44.3%), and GDS-score 7 (34%),
F(2,214)= 1.862, p= .158, η2= .017.
Course of SIB-S domains over time
For the whole sample, there was a significant average decline in
Semantic memory (F(1,115.267)=55.425; p< .001), Episodic
memory (F(1,476.310)= 26.045; p< .001), and Memory-
Orientation-Attention (F(1,451.032)=61.151; p< .001).
Baseline GDS-score had a significant effect on the rate of
decline in Semantic memory (F(2,106.473)= 9.418;
p< .001) and Memory-Orientation-Attention
(F(2,92.064)= 4.992; p= .009), but a non-significant effect
on Episodic memory (F(2,496.335)= 3.103; p= .050). As
the effect on Episodic memory was marginally significant,
we also conducted post hoc tests for this subscale. In accor-
dance with total SIB-S scores, Semantic memory declined
significantly faster for persons with GDS-score 6 compared
to persons with GDS-score 5 (t(109.734)= 2.856; p= .005)
or GDS-score 7 (t(107.059)= 4.102; p< .001). For Episodic
memory, however, only persons with GDS-score 6 declined
significantly faster than persons with GDS-score 7,
t(492.516)= 2.437, p= .015. In addition, also for Memory-
Orientation-Attention only persons with GDS-score 6
declined significantly faster than persons with GDS-score 7,
t(93.067)= 3.197, p= .002. For decline of domains per GDS-
score, see Table 4.
Relation Between Individual Items and Overall
Cognition
Figure 2 shows the ranking of the normalized mean score of
the SIB-S items by howmany patients could still successfully
complete the item. The response on item 1 (shake hands) was
mostly correct, while the response on item 12 (delayed recall
of examiner’s name) was mostly incorrect. The large standard
deviation of the mean normalized score of the items indicates
substantial variation between participants in their response on
the items. Furthermore, it was mainly the items concerning
episodic memory (item 12 and 25) and praxis/construction
(items 5, 14, and 24) that were the hardest for participants
with moderate to severe dementia.
After ranking the items, we separated our participants into
six groups based on their total SIB-S score: 0 (n= 78), 1–14
(n= 138), 15–31 (n= 140), 32–41 (n= 135), 42–49 (n= 148),
and 50 (n= 6). Figure 3 shows the items ranked based on the
whole population, but with the mean normalized SIB-S score
per item per group. The pattern found earlier for the whole
Table 5. Mean SIB-S scores on successive assessments for the
whole sample
N Mean (SD) Range
T0 217 27.50 (15.48) 0–50
T1 149 26.81 (17.61) 0–50
T2 117 23.49 (18.03) 0–50
T3 92 20.97 (17.66) 0–49
T4 70 19.93 (18.99) 0–50
N, number of participants; SD, standard deviation.
Fig. 1. Course of SIB-S scores over time for persons with
moderate to severe dementia according to dementia stage (without
a correction for age). The bold lines represent the mean course of
SIB-S scores per GDS-score and the thin lines represent the course
of SIB-S scores for each individual participant.
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sample can also be seen in the ranking by subgroups. The
variation of the mean normalized score of the items was
smaller when divided by subgroups, especially in the groups
with the lowest and highest total SIB-S scores. The hardest
items showed little or no variation in the group with a SIB-S
score 1–14. For example, all the participants with a SIB-S
score 1–14 had an incorrect response on items concerning
episodic memory (items 12 and 25) and praxis/construction
(items 5, 6, and 14). In the group with a SIB-S score 42–49, the
variation was the smallest for the easiest items.
DISCUSSION
This is the first study that examined the ability of the SIB-S to
measure cognitive change in institutionalized persons with
Fig. 2. Ranking of the items by how many participants could still successfully complete the item. As a measure for the items completion
rate, per item the mean normalized SIB-S score was calculated. The average (represented by bullets) and associated standard deviation
(represented by lines) were taken over all participants and all tests.
Fig. 3. Ranking of the items by how many participants could still successfully complete the item per group (classified by total SIB-S
score). The ranking was based on the whole population. As a measure for the item’s completion rate, per item the mean normalized SIB-S
score was calculated per group. The mean normalized SIB-S score was calculated by taking the average (represented by bullets) and
associated standard deviation (represented by lines) over all participants within one group.
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moderate to severe dementia. Mean total scores on the SIB-S
declined over a 2-year period, and the rate of decline differed
between dementia stages at baseline. The decline of SIB-S
scores was more rapid for persons with moderately severe
dementia than for persons with moderate or severe dementia
suggesting a modest floor and slight ceiling effect for the
SIB-S. Furthermore, we explored if the ability of participants
to complete semantic, non-semantic, and episodic items of
the SIB-S was related to their diagnosed dementia stage and
to their overall cognitive functioning. For semantic memory
items, the pattern of decline for different dementia stages was
similar as for SIB-S total scores. However, for episodic and
non-semantic memory items, only persons with moderately
severe dementia declined faster than persons with severe
dementia.
While we observed a decline for all three item categories
for persons with moderately severe dementia, we only
observed a decline in episodic and non-semantic memory
items in persons with moderate dementia and a decline in
semantic memory items in persons with severe dementia. In
addition, our item rankings showed that persons with the
lowest overall cognitive functioning had severe problems
with items regarding episodic memory and praxis.
The decline over time found in persons with moderate to
severe dementia suggests that mapping the course of cognitive
functioning with the SIB-S is possible in this population. The
faster decline in SIB-S scores for persons with moderately
severe dementia than for person with moderate or severe
dementia indicates, however, a modest floor and a slight ceiling
effect. For some participants with moderate dementia, the
questions of the SIB-S were probably too easy to adequately
map their cognitive abilities. Indeed, Figure 1 shows that a lar-
ger proportion of the participants in the group with moderate
dementia had relatively higher, more stable SIB-S scores than in
the group with moderately severe dementia. This was probably
due to the high number of semantic items in the SIB-S.
Studies have shown that mild AD patients were able to
visually recognize and correctly name and match words and
pictures (word-picture matching), a finding that suggests that
aspects of semantic memory were still intact (Hirono et al.,
2001; Hodges & Patterson, 1995). Probably, aspects of
semantic memory are also intact in the moderate stage of
dementia, and these aspects deteriorate mainly in the mod-
erately severe stage of dementia. It was indeed only semantic
memory that showed an accelerated decline in SIB-S scores
in the moderately severe dementia group in comparison to the
moderate dementia group.
Additionally, for some participants with severe dementia,
the questions of the SIB-S were probably too difficult. For
persons with a baseline SIB-S score close to zero, it is not
possible to decline much further in SIB-S scores. As can be
seen in Figure 1, part of the participants in the group with
severe dementia scored close to zero at every assessment.
Furthermore, in persons with severe dementia, we only
observed a decline in semantic memory. Our item ranking
showed that two episodic memory items were impossible for
persons with the lowest overall cognitive scores. It is possible
that semantic memory is the only memory system that can
decline when persons are in the severe stage of dementia.
Therefore, the small non-semantic part of the SIB-S could
also have contributed to the slower decline in SIB-S scores in
the severe dementia group in comparison to the moderately
severe dementia group. Additional studies with tests specifi-
cally developed to tap into different types of memory in
advanced dementia may provide additional insight.
A similar pattern, a slower decline in cognitive functioning
in the groups with the lowest and highest baseline-scores in
comparison to the middle group, has also been found for
other cognitive tests for dementia, including the original SIB
(Schmitt et al., 1997), MMSE (Morris et al., 1993), and
Alzheimer’s Disease Assessment Scale (Stern et al., 1994).
Only the population included in the study of the original SIB
was comparable to our population, while the other studies
also contained participants with mild dementia and had fewer
participants with very severe dementia. Therefore, it seems
difficult to draw conclusions about what dementia stage
shows the fastest cognitive decline.
It seems more likely that found differences in rate of cog-
nitive decline between dementia stages are a test effect
instead of a population effect. An alternative explanation is
that in our study the group with moderately severe dementia
at baseline had the largest score range on the SIB-S. The
value of a correlation between variables can be larger when
there is more variability among test scores (Goodwin &
Leech, 2006). Although the SIB-S thus seems most suitable
in the moderately severe stage of dementia, our finding of
decline in all examined dementia stages suggests that the
SIB-S is a useful tool to track cognition in the entire range of
moderate to severe dementia.
There was, however, considerable individual variability in
total SIB-S scores over time, especially among participants
with moderately severe dementia at baseline. A striking
finding was the relatively high percentage (23.7%) of parti-
cipants that had a SIB-S score that was higher at their last
than at their first assessment. One of the explanations for the
variability in SIB-S scores is that cognitive fluctuations
(spontaneous alterations in cognition, attention, and arousal)
are quite common among persons with dementia (Lee,
Taylor, & Thomas, 2012).
Second, we did not control for time of day participants
were tested. If a participant was most lucid in the morning,
but was tested at different times of the day across assess-
ments, this could have affected the results. Furthermore,
participants received treatment when necessary. This was,
however, not registered nor controlled for. If a significant
number of participants received treatment with a positive
effect on cognitive functioning, this could have led to the
relatively high percentage of participants that improved on
the SIB-S during our study. Future studies into the course of
cognitive functioning in dementia should control for time of
day of assessments, and whenever possible, also for received
treatments with an effect on cognitive functioning.
Next to cognitive fluctuations, the individual variability in
total SIB-S scores could also be caused by the relatively high
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SEM of the SIB-S. For example, for the first assessment, the
68% confidence interval around a participant’s “true” SIB-S
score was ±3.21 points. Thus individual variability on the
SIB-S could partly be explained by fluctuations around a
participant’s “true” score. One method to estimate the prob-
ability that an individual’s change in test scores is not due to
chance is calculating the Reliable Change Index (RCI) for
that particular test (Chelune, Naugle, Lüders, Sedlak &
Awad, 1993). Unfortunately, to calculate the RCI the test–
retest reliability coefficient is required, which was not avail-
able in our study. Future studies could calculate the RCI for
the SIB-S to draw stronger conclusions about what represents
clinically significant decline in dementia.
There were some other limitations. There were far more
women than men in our study. Women tend to have a faster
age-related cognitive decline and a higher risk of developing
AD than men (Li & Singh, 2014). The imbalance in gender
could have affected results. However, women live longer
than men on average, and consequently there are more
women than men with advanced dementia in institutions.
Therefore, our sample is representative for institutionalized
persons with dementia, but caution is warranted when gen-
eralizing our results to institutionalized men with dementia.
Another limitation was that only 70 of the 217 partici-
pants completed the last assessment. Main reasons for
dropping out were death and terminal disease. Participants
that dropped out were on average older than participants that
completed the last assessment. Unfortunately, this was a
consequence of the included population, persons with more
advanced dementia. To still include all participants in our
analyses, we analyzed our data with mixed models to handle
missing data.
Dementia subtype was not specifically examined in this
study. A specific dementia diagnosis was often inconclusive
as neuroimaging data were not routinely available. Neuroi-
maging can help to distinguish different dementia subtypes
more reliably (Health Quality Ontario, 2014). However, it is
not common practice to use neuroimaging for the diagnosis
of dementia subtypes in institutionalized persons. Further-
more, distinguishing between dementia subtypes becomes
harder above the age of 80 as there is mainly mixed pathology
in this group (Fotuhi, Hachinski, & Whitehouse, 2009). So,
we believe our results bear relevance to institutionalized
populations with moderate to severe dementia. The course of
cognitive functioning can be affected by dementia subtype;
however, the effects of dementia subtype on the course of
SIB-S scores warrant further research.
In conclusion, this is the first study that used the SIB-S to
examine the course of cognitive functioning across different
dementia stages. We found that it is feasible to measure
cognitive decline in advanced dementia. Although certain
SIB-S items regarding praxis and episodic memory will
provide no additional information in persons with the lowest
cognitive functioning, we recommend administering all
SIB-S items in every dementia stage. It is a relatively short
test to administer and there is a preconceived order in the
SIB-S items. For persons in the moderate dementia stage who
score near maximum on the SIB-S, additional tests less
focused on semantic memory could be necessary to get a
complete picture of their cognitive functioning at that
moment. However, we recommend using the SIB-S from the
moment a person reaches the moderate stage of dementia as
the SIB-S is one of few available tests that can still track
cognitive functioning even when a person eventually reaches
the severe stage of dementia.
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